Responses
Regular Abstracts – Part 2
Biomarkers, Immune Monitoring and Novel Technologies
222-E Integrative spatial multi-omics analysis of NSCLC tumor microenvironment identifies key features associated with response to immune checkpoint inhibitor therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
